Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: June 2009
-
By Donald Zuhn — In a follow-on biologics report that has received widespread media attention, the Federal Trade Commission concluded last week that a 12-14 year data exclusivity period was not needed to promote innovation by pioneer biologics companies (see "No One Seems Happy with Follow-on Biologics According to the FTC"). The FTC's conclusion…
-
By Kevin E. Noonan — Sickle cell anemia was the first known human disease associated with a genetic polymorphism (an A→T single nucleotide polymorphism, or SNP), resulting in the substitution of a valine residue (encoded by a GTG codon) for a glutamic acid residue (encoded by a GAG codon) in the beta chain of…
-
By Christopher P. Singer — In a Notice published in the Federal Register (74 Fed. Reg. 28473) on Tuesday, June 16, 2009, the U.S. Patent and Trademark Office announced an additional public comment period relating to a potential deferred patent examination pathway. This additional period for submitting comments expires on August 31, 2009. As…
-
By Donald Zuhn — Senate Judiciary Chairman Patrick Leahy (D-VT) released a statement today indicating that President Obama intends to nominate David Kappos (at right) to be the Undersecretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office. Senator Leahy stated that Mr. Kappos' experience as a development engineer…
-
By Suresh Pillai — Settlement Announced in Oxycontin® Litigation KV Pharmaceutical Co. announced a settlement in its litigation with Purdue Pharma LP over the painkiller Oxycontin® (see "Court Report," June 11, 2007). The settlement resolves three lawsuits filed by Purdue in the U.S. District Court for the Southern District of New York. Purdue launched…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office posted a notice on its website today announcing that the next meeting of the Patent Public Advisory Committee (PPAC) will be held on June 18, 2009. The meeting will be held on the USPTO campus, Madison North Auditorium, Concourse Level, 600 Dulany Street,…
-
By Kevin E. Noonan — Academics are useful people — they provoke us to think and rethink our assumptions and the consequences of our institutions and practices, and can expand them in unexpected and frequently useful ways. But they also tend to live in a world constructed within the boundaries of their own skulls,…
-
By Christopher P. Singer — Earlier this month, the U.S. Patent and Trademark Office sent out by e-mail its latest e-Commerce e-Alert, this one entitled "Tips to Improve Your e-Filing Effectiveness." Included in the e-Alert were four general procedures that help to streamline electronic prosecution through the use of EFS-Web and Private PAIR. Patent…
-
By Kevin E. Noonan — The zeitgeist has turned harshly on patenting in the U.S., perhaps nowhere as starkly as in gene patenting. Originally the subject of op-ed rants by famous authors (see "Science Fiction in The New York Times") and quixotic bills introduced by undistinguished members of Congress (see "The Continuing Threat to…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office recently unveiled a beta test release of its new website. According to the USPTO, the new site has been designed to improve the overall look and feel, as well as to enhance the user experience with improved navigation. The USPTO's goal of the…
Patent Docs 